Evidence map›Paper›PMID 30012268›Full record

Trial reportThe Lancet. Global health2018

Exposure to improved nutrition from conception to age 2 years and adult cardiometabolic disease risk: a modelling study.

Nicole D Ford, Jere R Behrman, John F Hoddinott, John A Maluccio, Reynaldo Martorell, Manuel Ramirez-Zea, Aryeh D Stein

Erratum issuedOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Lancet. Global health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Early life predictors of body composition trajectories from adolescence to mid-adulthood.American journal of human biology : the official journal of the Human Biology Council · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Nicole D FordHubert Department of Global Health, Rollins School of Public Health Emory University, Atlanta, GA, USA.
Jere R BehrmanDepartments of Economics and Sociology, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.
John F HoddinottDivision of Nutritional Sciences and Charles H Dyson School of Applied Economics and Management, Cornell University, Ithaca, NY, USA.
John A MaluccioDepartment of Economics, Middlebury College, Middlebury, VT, USA.
Reynaldo MartorellHubert Department of Global Health, Rollins School of Public Health Emory University, Atlanta, GA, USA.
Manuel Ramirez-ZeaInstitute of Nutrition of Central America and Panama Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala.
Aryeh D SteinHubert Department of Global Health, Rollins School of Public Health Emory University, Atlanta, GA, USA. Electronic address: aryeh.stein@emory.edu.
Emory University · USCornell University · USInstitute of Nutrition of Central America and Panama · GTMiddlebury College · USUniversity of Pennsylvania · US

Funding

Early childhood nutrition and adult metabolomic and cardiometabolic profilesR01HD075784 · NICHD · EMORY UNIVERSITY · PI STEIN, ARYEH DAVID · 2014 to 2018
$2.7M
NICHD NIH HHS R01 HD075784
6 · The paper itself

Abstract

backgroundLow-income and middle-income countries with populations that are chronically undernourished in early life are undergoing a nutrition transition and are experiencing an epidemic of cardiometabolic disease. These dual burdens are thought to be causally related; therefore, the extent to which improvements in early-life nutrition can offset adult-onset disease is important. The aim of this study was to examine whether improvement of protein-energy nutrition from conception to age 2 years can attenuate the risk of cardiometabolic disease.

methodsWe followed up a cohort of 2392 individuals born between Jan 1, 1962, and Feb 28, 1977, in four villages in Guatemala who had participated in a cluster-randomised protein-energy nutritional supplementation (Atole) trial. Of 1661 participants available for follow-up from Feb 26, 2015, to April 29, 2017, we studied 684 women and 455 men. We assessed cardiometabolic disease risk at ages 37-54 years using anthropometry, fasting and post-challenge glucose, fasting lipid concentrations, and blood pressure. We used generalised linear and logistic regression modelling to estimate the effect of Atole from conception to age 2 years (the first 1000 days) on cardiometabolic disease risk.

findingsExposure to Atole from conception to age 2 years was associated with increased fatness (body-mass index [1·29 kg/m

interpretationImproved protein-energy nutrition from conception to the 2nd birthday reduced the odds of diabetes at ages 37-54 years; however, this protein-energy supplementation also increased the risk of obesity and several obesity-related conditions. Our findings suggest a mixed ability of protein-energy nutritional supplementation in early life to prevent adult cardiometabolic disease incidence in the context of high childhood stunting and high adult overweight and obesity.

fundingNational Institutes of Health.

Indexed as

Dietary SupplementsNutritional Physiological PhenomenaAdultCardiovascular DiseasesChild, PreschoolDietary ProteinsFemaleFollow-Up StudiesGuatemalaHumansInfantInfant, NewbornMaleMiddle AgedPregnancyRiskDietary Proteins

Identifiers

PMID30012268
PMCPMC6138451
OpenAlexW2883968288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.